CORC

在结果中检索

CORC

浏览/检索结果: 共811条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文
CANCER MEDICINE, 2022
作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Liu, Xin;  Fu, Meng;  Xia, Daqing;  Ji, Zimei;  Hu, Nana
收藏  |  浏览/下载：12/0  |  提交时间：2022/12/22
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study 期刊论文
CANCERS, 2022, 卷号: 14
作者:  Xie, Mingying;  Li, Na;  Xu, Xiaoling;  Xu, Yanjun;  Li, Hui
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22
Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Fu, Meng;  Feng, Chun-Mei;  Xia, Da-Qing;  Ji, Zi-Mei;  Xia, Huai-Ling
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
A phase Ib/II study of AK112, a PD-1/VEGF bispecific antibody, as first- or second-line therapy for advanced non-small cell lung cancer (NSCLC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Zhou, Caicun;  Ren, Shengxiang;  Luo, Yongzhong;  Wang, Lei;  Xiong, Anwen
收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan
收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan
收藏  |  浏览/下载：10/0  |  提交时间：2022/12/22
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23
作者:  He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie
收藏  |  浏览/下载：29/0  |  提交时间：2022/06/10
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi
收藏  |  浏览/下载：17/0  |  提交时间：2022/05/05
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng
收藏  |  浏览/下载：100/0  |  提交时间：2022/03/21

©版权所有 ©2017 CSpace - Powered by CSpace